PMID- 31112000 OWN - NLM STAT- MEDLINE DCOM- 20200819 LR - 20231014 IS - 1752-8062 (Electronic) IS - 1752-8054 (Print) IS - 1752-8054 (Linking) VI - 12 IP - 5 DP - 2019 Sep TI - Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques. PG - 519-528 LID - 10.1111/cts.12647 [doi] AB - Applying data mining and machine learning (ML) techniques to clinical data might identify predictive biomarkers for diabetic nephropathy (DN), a common complication of type 2 diabetes mellitus (T2DM). A retrospective analysis of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was intended to identify such factors using ML. The longitudinal data were stratified by time after patient enrollment to differentiate early and late predictors. Our results showed that Random Forest and Simple Logistic Regression methods exhibited the best performance among the evaluated algorithms. Baseline values for glomerular filtration rate (GFR), urinary creatinine, urinary albumin, potassium, cholesterol, low-density lipoprotein, and urinary albumin to creatinine ratio were identified as DN predictors. Early predictors were the baseline values of GFR, systolic blood pressure, as well as fasting plasma glucose (FPG) and potassium at month 4. Changes per year in GFR, FPG, and triglycerides were recognized as predictors of late development. In conclusion, ML-based methods successfully identified predictive factors for DN among patients with T2DM. CI - (c) 2019 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. FAU - Rodriguez-Romero, Violeta AU - Rodriguez-Romero V AD - Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. AD - Indiana Clinical and Translational Sciences Institute (CTSI), Indianapolis, Indiana, USA. FAU - Bergstrom, Richard F AU - Bergstrom RF AD - Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. AD - Indiana Clinical and Translational Sciences Institute (CTSI), Indianapolis, Indiana, USA. FAU - Decker, Brian S AU - Decker BS AD - Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. FAU - Lahu, Gezim AU - Lahu G AD - Translational Research and Early Clinical, Takeda Pharmaceutical International Co., Cambridge, Massachusetts, USA. FAU - Vakilynejad, Majid AU - Vakilynejad M AD - Translational Research and Early Clinical, Takeda Pharmaceutical International Co., Cambridge, Massachusetts, USA. FAU - Bies, Robert R AU - Bies RR AD - Indiana Clinical and Translational Sciences Institute (CTSI), Indianapolis, Indiana, USA. AD - Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York, USA. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190531 PL - United States TA - Clin Transl Sci JT - Clinical and translational science JID - 101474067 RN - 0 (Biomarkers) SB - IM MH - Biomarkers/metabolism MH - Data Mining MH - Diabetes Mellitus, Type 2/*complications MH - Diabetic Nephropathies/*complications/*diagnosis/epidemiology MH - Female MH - Humans MH - Incidence MH - *Machine Learning MH - Male MH - Middle Aged MH - Models, Theoretical MH - ROC Curve MH - Risk Factors MH - Sensitivity and Specificity PMC - PMC6742939 COIS- All authors declared no competing interests for this work. EDAT- 2019/05/22 06:00 MHDA- 2020/08/20 06:00 PMCR- 2019/09/01 CRDT- 2019/05/22 06:00 PHST- 2018/12/07 00:00 [received] PHST- 2019/04/21 00:00 [accepted] PHST- 2019/05/22 06:00 [pubmed] PHST- 2020/08/20 06:00 [medline] PHST- 2019/05/22 06:00 [entrez] PHST- 2019/09/01 00:00 [pmc-release] AID - CTS12647 [pii] AID - 10.1111/cts.12647 [doi] PST - ppublish SO - Clin Transl Sci. 2019 Sep;12(5):519-528. doi: 10.1111/cts.12647. Epub 2019 May 31.